- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04133688
Mobile App in Addiction (ASC-Val)
October 15, 2021 updated by: Assistance Publique - Hôpitaux de Paris
A Mobile App for the Self Quantification of Sleep and Behaviors : a Pilot Study With Teenagers and Young Adults
The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance.
In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.
Study Overview
Detailed Description
The sleep and behavior agendas are today very largely underused while they can be of a considerable contribution in the follow-up of the patients and the reinforcement of the therapeutic alliance.
In the management of addictions, sleep disorders are a major comorbidity, these two components maintain indeed complex links: it was highlighted a bidirectional relationship between the effect of the consumption of addictive substances on sleep and conversely, the effect of sleep disorders on the consumption of products, the same is true for overexposure to screens.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75019
- Robert Debre Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Teenagers or young adults from 12 to 18 years old (included)
- Consultant for addiction to cannabis and / or tobacco and / or alcohol and / or screen
- Treated within the Functional Unit of addictology
- For minors, after parental consent
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mobile application (ASC)
mobile app / devise
|
mobile app
Other Names:
|
Active Comparator: Paper diary
paper diary
|
mobile app
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of days filled for sleep and consumptions, usable by the doctor on the day of the consultation / after 15 days of self-evaluation required by the treatment
Time Frame: 15 days
|
15 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Benjamin Pitrat, MD, APHP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 30, 2019
Primary Completion (Actual)
October 6, 2020
Study Completion (Actual)
October 6, 2020
Study Registration Dates
First Submitted
October 18, 2019
First Submitted That Met QC Criteria
October 18, 2019
First Posted (Actual)
October 21, 2019
Study Record Updates
Last Update Posted (Actual)
October 18, 2021
Last Update Submitted That Met QC Criteria
October 15, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-A01374-51
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Addiction
-
The Hong Kong Polytechnic UniversityRecruiting
-
City University of Hong KongCompletedQuality of Life | Psychological Distress | Internet Gaming Disorder | Social Media Addiction | Smartphone AddictionChina
-
Gazi UniversityRecruitingAddiction | Physical Inactivity | Social Media AddictionTurkey
-
The Hong Kong Polytechnic UniversityRecruitingPrevalence of Internet Addiction and it's Effects on Psychological Well-being of Adults in Hong KongInternet AddictionHong Kong
-
Dr. Wang Man-PingActive, not recruiting
-
Mustafa YumusakCumhuriyet UniversityNot yet recruitingSmartphone Addiction | Students, NursingTurkey
-
Kutahya Health Sciences UniversityCompletedMental Fatigue | Smartphone AddictionTurkey
-
Bar-Ilan University, IsraelRecruitingInfant Behavior | Breastfeeding | Mother-Infant Interaction | Smartphone AddictionIsrael
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedSmartphone Users, Smartphone Addiction, Anxiety, and Skin ConductanceTaiwan
-
Suleyman Demirel UniversityCompleted
Clinical Trials on ASC
-
Anterogen Co., Ltd.RecruitingCrohn's DiseaseKorea, Republic of
-
Gannex Pharma Co., Ltd.Hunan Provincial People's HospitalCompletedNAFLD | Overweight and Obesity | HyperlipidemiaChina
-
University Hospital, GrenobleNot yet recruitingAutism Spectrum Disorder
-
Apica Cardiovascular LimitedCompleted
-
University Hospital, MontpellierAssistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de... and other collaboratorsActive, not recruiting
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioRecruiting
-
Anterogen Co., Ltd.Completed
-
Pharmbio Korea Co., Ltd.Not yet recruitingIntestinal Disease | Colonic Disease
-
Ageless Regenerative InstituteInstituto de Medicina RegenerativaWithdrawn
-
Anterogen Co., Ltd.CompletedDiabetic Foot UlcerKorea, Republic of